{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:32:13Z","timestamp":1768411933484,"version":"3.49.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["americanjournalofsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.amjsurg.2022.11.036","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T01:08:32Z","timestamp":1670202512000},"page":"583-587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Contemporary approaches to the axilla in breast cancer"],"prefix":"10.1016","volume":"225","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8025-9220","authenticated-orcid":false,"given":"Jessica L.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Paul","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.amjsurg.2022.11.036_bib1","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial","volume":"252","author":"Giuliano","year":"2010","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.amjsurg.2022.11.036_bib2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.amjsurg.2022.11.036_bib3","first-page":"501","article-title":"Landmark trials affecting the surgical management of invasive breast cancer","volume":"93","author":"Black","year":"2013","journal-title":"Surg Clin"},{"issue":"3","key":"10.1016\/j.amjsurg.2022.11.036_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"Giuliano","year":"2016","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.amjsurg.2022.11.036_bib5","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.amjsurg.2022.11.036_bib6","series-title":"NCCN Clinical Practice Guidelines in Oncology. Breast Cancer","year":"2022"},{"issue":"10","key":"10.1016\/j.amjsurg.2022.11.036_bib7","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1245\/s10434-021-10441-z","article-title":"A national survey of breast surgeons and radiation oncologists on contemporary axillary management in mastectomy patients","volume":"28","author":"Cortina","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.amjsurg.2022.11.036_bib8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10549-019-05243-7","article-title":"Evolution in practice patterns of axillary management following mastectomy in patients with 1-2 positive sentinel nodes","volume":"176","author":"Weiss","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.amjsurg.2022.11.036_bib9","article-title":"Consensus guideline on axillary management for patients with in-situ and invasive breast cancer: a concise overview","volume":"14","year":"2022","journal-title":"Aprrove March"},{"issue":"12","key":"10.1016\/j.amjsurg.2022.11.036_bib10","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/jcp.55.12.926","article-title":"Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients","volume":"55","author":"Cserni","year":"2002","journal-title":"J Clin Pathol"},{"issue":"6","key":"10.1016\/j.amjsurg.2022.11.036_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2559.2005.02143.x","article-title":"Evaluation of sentinel lymph nodes in breast cancer","volume":"46","author":"Cserni","year":"2005","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.amjsurg.2022.11.036_bib12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.amjsurg.2022.11.036_bib13","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial","volume":"19","author":"Galimberti","year":"2018","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.amjsurg.2022.11.036_bib14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1245\/s10434-012-2569-y","article-title":"Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000","volume":"20","author":"Sol\u00e1","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.amjsurg.2022.11.036_bib15","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1245\/s10434-016-5605-5","article-title":"Outcomes of sentinel lymph node-positive breast cancer patients treated with mastectomy without axillary therapy","volume":"24","author":"Fitzsullivan","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"29","key":"10.1016\/j.amjsurg.2022.11.036_bib16","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1200\/JCO.20.00459","article-title":"Quantifying the impact of axillary surgery and nodal irradiation on breast cancer-related lymphedema and local tumor control: long-term results from a prospective screening trial","volume":"38","author":"Naoum","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.amjsurg.2022.11.036_bib17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12885-017-3361-y","article-title":"Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial","volume":"17","author":"De Boniface","year":"2017","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.amjsurg.2022.11.036_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-054365","volume":"11","author":"Goyal","year":"2021","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.amjsurg.2022.11.036_bib19","doi-asserted-by":"crossref","first-page":"9534","DOI":"10.1038\/s41598-021-88716-4","article-title":"Prognostic value of extranodal extension in axillary lymph node-positive breast cancer","volume":"11","author":"Ma","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjsurg.2022.11.036_bib20","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1245\/s10434-014-3752-0","article-title":"The extent of extracapsular extension may influence the need for axillary lymph node dissection in patients with T1-T2 breast cancer","volume":"21","author":"Gooch","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.amjsurg.2022.11.036_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0360-3016(95)00081-9","article-title":"Microscopic extracapsular extension in the axilla: is this an indication for axillary radiotherapy?","volume":"33","author":"Pierce","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.amjsurg.2022.11.036_bib22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1054\/brst.2000.0233","article-title":"Implications of extranodal spread in node positive breast cancer: a review of survival and local recurrence","volume":"10","author":"Bucci","year":"2001","journal-title":"Breast"},{"issue":"4","key":"10.1016\/j.amjsurg.2022.11.036_bib23","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0002-9610(01)00719-X","article-title":"Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer","volume":"182","author":"Abdessalam","year":"2001","journal-title":"Am J Surg"},{"issue":"7","key":"10.1016\/j.amjsurg.2022.11.036_bib24","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ejso.2016.02.259","article-title":"Extra-nodal extension of sentinel lymph node metastasis is a marker of poor prognosis in breast cancer patients: a systematic review and an exploratory meta-analysis","volume":"42","author":"Nottegar","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.amjsurg.2022.11.036_bib25","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1245\/s10434-019-08104-1","article-title":"Microscopic extracapsular extension in sentinel lymph nodes does not mandate axillary dissection in z0011-eligible patients","volume":"27","author":"Barrio","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"25","key":"10.1016\/j.amjsurg.2022.11.036_bib26","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","article-title":"21-Gene assay to inform chemotherapy benefit in node-positive breast cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"N Engl J Med"},{"issue":"34","key":"10.1016\/j.amjsurg.2022.11.036_bib27","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1200\/JCO.20.02514","article-title":"Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER2\u2212, node-positive, high-risk, early breast cancer (monarchE)","volume":"38","author":"Johnston","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjsurg.2022.11.036_bib28","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.22.00173","article-title":"Impact of RxPONDER and monarchE on the surgical management of the axilla in patients with breast cancer","author":"Mittendorf","year":"2022","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.amjsurg.2022.11.036_bib29","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1245\/s10434-022-12193-w","article-title":"How Often Do Sentinel Lymph Node Biopsy Results Affect Adjuvant Therapy Decisions Among Postmenopausal Women with Early-Stage HR+\/HER2- Breast Cancer in the Post-RxPONDER Era?","volume":"29","author":"Pilewskie","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.amjsurg.2022.11.036_bib30","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1245\/s10434-016-5330-0","article-title":"Impact of body mass index on clinical axillary nodal assessment in breast cancer patients","volume":"23","author":"Mccartan","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.amjsurg.2022.11.036_bib31","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","article-title":"Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18","volume":"15","author":"Fisher","year":"1997","journal-title":"J Clin Oncol"},{"issue":"9938","key":"10.1016\/j.amjsurg.2022.11.036_bib32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.amjsurg.2022.11.036_bib33","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.0891","article-title":"Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease A systematic review and meta-analysis","volume":"156","author":"Samiei","year":"2021","journal-title":"JAMA Surg"},{"issue":"14","key":"10.1016\/j.amjsurg.2022.11.036_bib34","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.amjsurg.2022.11.036_bib35","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.amjsurg.2022.11.036_bib36","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10549-018-5004-7","article-title":"Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study","volume":"173","author":"Classe","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.amjsurg.2022.11.036_bib37","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.amjsurg.2022.11.036_bib38","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","volume":"263","author":"Boughey","year":"2016","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.amjsurg.2022.11.036_bib39","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.amjsurg.2022.11.036_bib40","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1245\/s10434-015-5052-8","article-title":"Axillary staging after neoadjuvant chemotherapy for breast cancer: a pilot study combining sentinel lymph node biopsy with radioactive seed localization of pre-treatment positive axillary lymph nodes","volume":"23","author":"Diego","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.amjsurg.2022.11.036_bib41","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.1245\/s10434-022-12240-6","article-title":"Is Nodal Clipping Beneficial for Node-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy?","volume":"29","author":"Montagna","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.amjsurg.2022.11.036_bib42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jamasurg.2014.1086","article-title":"Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer A prospective feasibility trial","volume":"150","author":"Caudle","year":"2015","journal-title":"JAMA Surg"},{"issue":"3","key":"10.1016\/j.amjsurg.2022.11.036_bib43","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1245\/s10434-017-6270-z","article-title":"Intraoperative ultrasound-guided excision of axillary clip in patients with node-positive breast cancer treated with neoadjuvant therapy (ILINA trial): a new tool to guide the excision of the clipped node after neoadjuvant treatment","volume":"25","author":"Siso","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.amjsurg.2022.11.036_bib44","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.clbc.2021.07.011","article-title":"MINImal vs. MAXimal invasive axillary staging and treatment after neoadjuvant systemic therapy in node positive breast cancer: protocol of a Dutch multicenter registry study (MINIMAX)","volume":"22","author":"de Wild","year":"2022","journal-title":"Clin Breast Cancer"},{"issue":"7","key":"10.1016\/j.amjsurg.2022.11.036_bib45","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.3390\/cancers13071565","volume":"29","author":"Banys-Paluchowski","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.amjsurg.2022.11.036_bib46","author":"Oncoplastic Breast Consortium (Opbc)"},{"issue":"15","key":"10.1016\/j.amjsurg.2022.11.036_bib48","volume":"37","author":"Mamounas","year":"2019","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.amjsurg.2022.11.036_bib49","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1245\/ASO.2006.03.010","article-title":"Size of residual lymph node metastasis after neoadjuvant chemotherapy in locally advanced breast cancer patients is prognostic","volume":"13","author":"Klauber-Demore","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.amjsurg.2022.11.036_bib50","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10549-010-1086-6","article-title":"Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study","volume":"127","author":"Maaskant-Braat","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.amjsurg.2022.11.036_bib51","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10549-017-4157-0","article-title":"Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases","volume":"163","author":"Van Nijnatten","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"10.1016\/j.amjsurg.2022.11.036_bib52","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1245\/s10434-019-07517-2","article-title":"Prognostic significance of residual axillary nodal micrometastases and isolated tumor cells after neoadjuvant chemotherapy for breast cancer","volume":"26","author":"Wong","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.amjsurg.2022.11.036_bib53","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1245\/s10434-016-5585-5","article-title":"Trends in neoadjuvant endocrine therapy use and impact on rates of breast conservation in hormone receptor-positive breast cancer: a national cancer data base study","volume":"24","author":"Chiba","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"10.1016\/j.amjsurg.2022.11.036_bib54","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1245\/s10434-019-07785-y","article-title":"Patterns of axillary management in stages 2 and 3 hormone receptor-positive breast cancer by initial treatment approach","volume":"26","author":"Weiss","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.amjsurg.2022.11.036_bib55","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41523-020-00177-6","article-title":"Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer","volume":"6","author":"Kantor","year":"2020","journal-title":"NPJ Breast Cancer"},{"issue":"10","key":"10.1016\/j.amjsurg.2022.11.036_bib56","doi-asserted-by":"crossref","first-page":"397","DOI":"10.46883\/ONC.2020.3410.0397","article-title":"Strategies to optimize axillary surgery in patients with breast cancer receiving neoadjuvant endocrine therapy","volume":"34","author":"Weiss","year":"2020","journal-title":"Oncology"},{"key":"10.1016\/j.amjsurg.2022.11.036_bib57","article-title":"Five things physicians and patients should question","author":"Society of Surgical Oncology","year":"2019","journal-title":"Choosing Wisely"},{"issue":"6","key":"10.1016\/j.amjsurg.2022.11.036_bib58","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1001\/jama.2012.84","article-title":"Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer","volume":"307","author":"Van De Water","year":"2012","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.amjsurg.2022.11.036_bib59","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00432-015-2111-2","article-title":"Tumor characteristics and therapy of elderly patients with breast cancer","volume":"142","author":"Grumpelt","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"issue":"19","key":"10.1016\/j.amjsurg.2022.11.036_bib60","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343","volume":"31","author":"Hughes","year":"2013","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.amjsurg.2022.11.036_bib61","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1245\/s10434-010-1217-7","article-title":"Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up","volume":"18","author":"Martelli","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.amjsurg.2022.11.036_bib62","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1200\/JCO.2005.01.5784","article-title":"Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group trial 10-93","volume":"24","author":"Rudenstam","year":"2006","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.amjsurg.2022.11.036_bib63","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMoa040587","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women 70 Years of age or older with early breast cancer","volume":"351","author":"Hughes","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.amjsurg.2022.11.036_bib64","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1470-2045(14)71221-5","article-title":"Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial","volume":"16","author":"Kunkler","year":"2015","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.amjsurg.2022.11.036_bib65","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1245\/s10434-020-08388-8","article-title":"Trends in surgical axillary management in early stage breast cancer in elderly women: continued over-treatment","volume":"27","author":"Louie","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.amjsurg.2022.11.036_bib66","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/jamasurg.2020.0322","article-title":"Deimplementation of the choosing wisely recommendations for low-value breast cancer surgery: a systematic review","volume":"155","author":"Wang","year":"2020","journal-title":"JAMA Surg"},{"issue":"10","key":"10.1016\/j.amjsurg.2022.11.036_bib67","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1245\/s10434-021-10460-w","article-title":"Impact of choosing wisely recommendations on sentinel lymph node biopsy and postoperative radiation rates in women over age 70 Years with hormone-positive breast cancer","volume":"28","author":"Thompson","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.amjsurg.2022.11.036_bib68","first-page":"1675","article-title":"Superparamagnetic iron oxide nanoparticles as the sole method for sentinel node biopsy detection in patients with breast cancer","volume":"104","author":"Karakatsanis","year":"2017","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.amjsurg.2022.11.036_bib69","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/1457496917738867","article-title":"Simplifying logistics and avoiding the unnecessary in patients with breast cancer undergoing sentinel node biopsy. A prospective feasibility trial of the preoperative injection of super paramagnetic iron oxide nanoparticles","volume":"107","author":"Karakatsanis","year":"2018","journal-title":"Scand J Surg"},{"issue":"12","key":"10.1016\/j.amjsurg.2022.11.036_bib76","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.3390\/cancers12123698","article-title":"Avoiding axillary sentinel lymph node biopsy after neoadjuvant systemic therapy in breast cancer: rationale for the prospective, multicentric EUBREAST-01 trial","volume":"12","author":"Reimer","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.amjsurg.2022.11.036_bib78","article-title":"NEONOD 2: rationale and design of a multicenter non-inferiority trial to assess the effect of axillary surgery omission on the outcome of breast cancer patients presenting only micrometastasis in the sentinel lymph node after neoadjuvant chemotherapy","volume":"17","author":"Tinterri","year":"2019","journal-title":"Contemp Clin Trials Commun"},{"issue":"1","key":"10.1016\/j.amjsurg.2022.11.036_bib79","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1186\/s13063-018-3021-9","article-title":"Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial","volume":"19","author":"Henke","year":"2018","journal-title":"Trials"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961022007760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961022007760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:27:09Z","timestamp":1757701629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002961022007760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0002961022007760"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2022.11.036","relation":{},"ISSN":["0002-9610"],"issn-type":[{"value":"0002-9610","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemporary approaches to the axilla in breast cancer","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2022.11.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}